Affinity Asset Advisors, LLC
Q1 2023 13F Holdings
- Locationnew york, NY
- Num holdings
74
- Value ($000)
$303,007
- Date Filed05/15/2023
- Form type13F-HR
- CIK0001773195
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2023 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
KDNY CHINOOK THERAPEUTICS INC | COM | 16961L106 | $22.59 M | 8 % | 976,021 | ||
MDGL MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | $22.53 M | 7 % | 93,000 | ||
SPY SPDR S&P 500 ETF TRTR UNIT | TR UNIT | 78462F103 | $18.42 M | 6 % | 45,000 | call | |
RXDX PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | $16.10 M | 5 % | 150,000 | ||
MRK MERCK & CO INC | COM | 58933Y105 | $12.77 M | 4 % | 120,000 | ||
VKTX VIKING THERAPEUTICS INC | COM | 92686J106 | $10.36 M | 3 % | 622,249 | ||
CBAY CYMABAY THERAPEUTICS INC | COM | 23257D103 | $9.44 M | 3 % | 1,083,118 | ||
CERE CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | $9.27 M | 3 % | 380,000 | ||
VRNA VERONA PHARMA PLC | SPONSORED ADR | 925050106 | $9.09 M | 3 % | 452,821 | ||
VTYX VENTYX BIOSCIENCES INC | COM | 92332V107 | $8.71 M | 3 % | 260,008 |
Rows Per Page
10
- 10
- 50
- 100